Publications for Graham Mann
Publications for Graham Mann
v066">[More Information]</a>
2016
Watts, C., Dieng, M., Morton, R., Mann, G.,
Menzies, S., Cust, A. (2015). Clinical practice
guidelines for identification, screening and
follow-up of individuals at high risk of primary
cutaneous melanoma: a systematic review.
British Journal of Dermatology, 172(1), 33-47.
<a
href="http://dx.doi.org/10.1111/bjd.13403">[Mo
re Information]</a>
De Paoli-Iseppi, R., Johansson, P., Menzies, A.,
Dias, K., Pupo, G., Kakavand, H., Wilmott, J.,
Mann, G., Hayward, N., Dinger, M., Long, G.,
Scolyer, R. (2016). Comparison of whole-exome
sequencing of matched fresh and formalin fixed
paraffin embedded melanoma tumours:
implications for clinical decision making.
Pathology, 48(3), 261-266. <a
href="http://dx.doi.org/10.1016/j.pathol.2016.01.
001">[More Information]</a>
Jayawardana, K., Schramm, S., Tembe, V.,
Mueller, S., Thompson, J., Scolyer, R., Mann,
G., Yang, J. (2016). Identification, Review, and
Systematic Cross-Validation of microRNA
Prognostic Signatures in Metastatic Melanoma.
Journal of Investigative Dermatology, 136(1),
245-254. <a
href="http://dx.doi.org/10.1038/JID.2015.355">[
More Information]</a>
Taylor, N., Handorf, E., Mitra, N., Avril, M.,
Azizi, E., Bergman, W., Bianchi-Scarra, G.,
Bishop, D., Bressac-de Paillerets, B., Cust, A.,
Holland, E., Mann, G., Olsson, H., Schmid, H.,
et al (2016). Phenotypic and Histopathological
Tumor Characteristics According to CDKN2A
Mutation Status among Affected Members of
Melanoma Families. Journal of Investigative
Dermatology, 136(5), 166-169. <a
href="http://dx.doi.org/10.1016/j.jid.2016.01.009
">[More Information]</a>
Lyle, M., Haydu, L., Menzies, A., Thompson, J.,
Saw, R., Spillane, A., Kefford, R., Mann, G.,
Cooper, W., Yu, B., Scolyer, R., O'Toole, S.,
Long, G. (2016). The molecular profile of
metastatic melanoma in Australia. Pathology,
48(2), 188-193. <a
href="http://dx.doi.org/10.1016/j.pathol.2015.12.
008">[More Information]</a>
2015
Cust, A., Pickles, K., Goumas, C., Vu, T.,
Schmid, H., Nagore, E., Kelly, J., Aitken, J.,
Giles, G., Hopper, J., Mann, G., et al (2015).
Accuracy of self-reported nevus and
pigmentation phenotype compared with clinical
assessment in a population-based study of young
Australian Adults. Cancer Epidemiology,
Biomarkers and Prevention, 24(4), 736-743. <a
href="http://dx.doi.org/10.1158/1055-9965.EPI-1
4-1203">[More Information]</a>
Strbenac, D., Mann, G., Ormerod, J., Yang, J.
(2015). ClassifyR: an R package for performance
assessment of classification with applications to
transcriptomics. Bioinformatics, 31(11),
1851-1853. <a
href="http://dx.doi.org/10.1093/bioinformatics/bt
Zdenkowski, N., Butow, P., Mann, B., Fewster,
S., Douglas, C., Boyle, F. (2015). Decisions
about neoadjuvant systemic therapy for breast
cancer: a survey of Australian and New Zealand
specialists. ANZ Journal of Surgery, 85(11),
797-799. <a
href="http://dx.doi.org/10.1111/ans.13266">[Mo
re Information]</a>
Jayawardana, K., Schramm, S., Haydu, L.,
Thompson, J., Scolyer, R., Mann, G., Muller, S.,
Yang, J. (2015). Determination of prognosis in
metastatic melanoma through integration of
clinico-pathologic, mutation, mRNA,
microRNA, and protein information.
International Journal of Cancer, 136(4),
863-874. <a
href="http://dx.doi.org/10.1002/ijc.29047">[Mor
e Information]</a>
Shain, A., Garrido, M., Botton, T., Talevich, E.,
Yeh, I., Sanborn, J., Chung, J., Wang, N.,
Kakavand, H., Mann, G., Thompson, J., Scolyer,
R., et al (2015). Exome sequencing of
desmoplastic melanoma identifies recurrent
NFKBIE promoter mutations and diverse
activating mutations in the MAPK pathway.
Nature Genetics, 47(10), 1194-1199. <a
href="http://dx.doi.org/10.1038/ng.3382">[More
Information]</a>
Law, M., Bishop, D., Lee, J., Brossard, M.,
Martin, N., Moses, E., Song, F., Barrett, J.,
Kumar, R., Easton, D., Mann, G., Cust, A., et al
(2015). Genome-wide meta-analysis identifies
five new susceptibility loci for cutaneous
malignant melanoma. Nature Genetics, 47(9),
987-995. <a
href="http://dx.doi.org/10.1038/ng.3373">[More
Information]</a>
Sargen, M., Kanetsky, P., Newtown-Bishop, J.,
Hayward, N., Mann, G., Gruis, N., Tucker, M.,
Goldstein, A., Bianchi-Scarra, G., Puig, S., et al
(2015). Histologic features of melanoma
associated with CDKN2A genotype. Journal Of
The American Academy Of Dermatology, 72(3),
496-507.e7. <a
href="http://dx.doi.org/10.1016/j.jaad.2014.11.01
4">[More Information]</a>
Howard, K., Salkeld, G., Patel, M., Mann, G.,
Pignone, M. (2015). Men's preferences and
Publications for Graham Mann
trade-offs for prostate cancer
screening: A discrete choice experiment. Health
Expectations, 18(6), 3123-3135. <a
href="http://dx.doi.org/10.1111/hex.12301">[Mo
re Information]</a>
Tembe, V., Schramm, S., Stark, M., Patrick, E.,
Jayaswal, V., Tang, Y., Barbour, A., Hayward,
N., Thompson, J., Scolyer, R., Yang, J., Mann,
G. (2015). microRNA and mRNA expression
profiling in metastatic melanoma reveal
associations with BRAF mutation and patient
prognosis. Pigment Cell & Melanoma Research,
28(3), 254-226. <a
href="http://dx.doi.org/10.1111/pcmr.12343">[
More Information]</a>
Aoude, L., Pritchard, A., Robles-Espinoza, C.,
Wadt, K., Harland, M., Choi, J., Gartside, M.,
Quesada, V., Johansson, P., Palmer, J., Holland,
E., Schmid, H., Mann, G., et al (2015). Nonsense
mutations in the shelterin complex genes ACD
and TERF2IP in familial melanoma. Journal of
the National Cancer Institute, 107(2), 1-7. <a
href="http://dx.doi.org/10.1093/jnci/dju408">[M
ore Information]</a>
Sanborn, J., Chung, J., Purdom, E., Wang, N.,
Kakavand, H., Wilmott, J., Butler, T.,
Thompson, J., Mann, G., Haydu, L., Saw, R.,
Scolyer, R., et al (2015). Phylogenetic analyses
of melanoma reveal complex patterns of
metastatic dissemination. Proceedings of the
National Academy of Sciences of the United
States of America (PNAS), 112(35),
10995-11000. <a
href="http://dx.doi.org/10.1073/pnas.150807411
2">[More Information]</a>
Arafeh, R., Qutob, N., Emmanuel, R.,
Keren-Paz, A., Madore, J., Elkahloun, A.,
Wilmott, J., Gartner, J., Di Pizio, A.,
Winograd-Katz, S., Mann, G., Scolyer, R., et al
(2015). Recurrent inactivating RASA2 mutations
in melanoma. Nature Genetics, 47(12),
1408-1410. <a
href="http://dx.doi.org/10.1038/ng.3427">[More
Information]</a>
Watts, C., Cust, A., Menzies, S., Coates, E.,
Mann, G., Morton, R. (2015). Specialized
surveillance for individuals at high risk for
melanoma a cost analysis of a high-risk clinic.
JAMA Dermatology, 151(2), 178-186. <a
href="http://dx.doi.org/10.1001/jamadermatol.20
14.1952">[More Information]</a>
Tiffen, J., Gunatilake, D., Gallagher, S.,
Gowrishankar, K., Heinemann, A., Cullinane, C.,
Dutton-Regester, K., Pupo, G., Strbenac, D.,
Yang, J., Madore, J., Mann, G., Hersey, P., et al
(2015). Targeting activating mutations of EZH2
leads to potent cell growth inhibition in human
melanoma by derepression of tumor suppressor
genes. Oncotarget, 6(29), 27023-27036. <a
href="http://dx.doi.org/10.18632/oncotarget.480
9">[More Information]</a>
Dieng, M., Kasparian, N., Morton, R., Mann, G.,
Butow, P., Menzies, S., Costa, D., Cust, A.
(2015). The Melanoma care study: protocol of a
randomised controlled trial of a
psycho-educational intervention for melanoma
survivors at high risk of developing new primary
disease. BMC Psychology, 3(1), 1-13. <a
href="http://dx.doi.org/10.1186/s40359-015-007
4-3">[More Information]</a>
Stark, M., Klein, K., Weide, B., Haydu, L.,
Pflugfelder, A., Tang, Y., Palmer, J., Whiteman,
D., Scolyer, R., Mann, G., Thompson, J., Long,
G., et al (2015). The Prognostic and Predictive
Value of Melanoma-related MicroRNAs Using
Tissue and Serum: A MicroRNA Expression
Analysis. EBioMedicine, 2(7), 671-680. <a
href="http://dx.doi.org/10.1016/j.ebiom.2015.05.
011">[More Information]</a>
Wilmott, J., Field, M., Johansson, P., Kakavand,
H., Shang, P., De Paoli-Iseppi, R., Vilain, R.,
Pupo, G., Tembe, V., Jakrot, V., Thompson, J.,
Mann, G., Scolyer, R., et al (2015). Tumour
procurement, DNA extraction, coverage analysis
and optimisation of mutation-detection
algorithms for human melanoma genomes.
Pathology, 47(7), 683-693. <a
href="http://dx.doi.org/10.1097/PAT.000000000
0000324">[More Information]</a>
Wong, S., Waldeck, K., Vergara, I., Schroder, J.,
Madore, J., Wilmott, J., Colebatch, A., De
Paoli-Iseppi, R., Li, J., Lupat, R., Hruby, G.,
Mann, G., Thompson, J., Scolyer, R., Gill, A., et
al (2015). UV-Associated Mutations Underlie the
Etiology of MCV-Negative Merkel Cell
Carcinomas. Cancer Research, 75(24),
5228-5234. <a
href="http://dx.doi.org/10.1158/0008-5472.CAN
-15-1877">[More Information]</a>
2014
Dutton-Regester, K., Gartner, J., Emmanuel, R.,
Qutob, N., Davies, M., Gershenwald, J.,
Robinson, W., Robinson, S., Rosenberg, S.,
Scolyer, R., Mann, G., Thompson, J., et al
(2014). A highly recurrent RPS27 5'UTR
mutation in melanoma. Oncotarget, 5(10),
2912-2917.
Moloney, F., Guitera, P., Coates, E., Haass, N.,
Ho, K., Khoury, R., O'Connell, R., Raudonikis,
L., Schmid, H., Mann, G., Menzies, S. (2014).
Detection of Primary Melanoma in Individuals at
Extreme High Risk: A Prospective 5-year
Follow-up Study. JAMA Dermatology, 150(8),
819-827. <a
href="http://dx.doi.org/10.1001/jamadermatol.20
14.514">[More Information]</a>
Publications for Graham Mann
Song, F., Amos, C., Lee, J., Lian, C., Fang, S.,
Liu, H., MacGregor, S., Iles, M., Law, M.,
Lindeman, N., Cust, A., Kefford, R., Armstrong,
B., Mann, G., et al (2014). Identification of a
melanoma susceptibility locus and somatic
mutation in TET2. Carcinogenesis, 35(9),
2097-2101. <a
href="http://dx.doi.org/10.1093/carcin/bgu140">
[More Information]</a>
Dieng, M., Watts, C., Kasparian, N., Morton, R.,
Mann, G., Cust, A. (2014). Improving subjective
perception of personal cancer risk: systematic
review and meta-analysis of educational
interventions for people with cancer or at high
risk of cancer. Psycho-Oncology, 23(6), 613-625.
<a
href="http://dx.doi.org/10.1002/pon.3476">[Mor
e Information]</a>
Lu, Y., Weronica, E., Whiteman, D., Vaughan,
T., Spurdle, A., Easton, D., Pharoah, P.,
Thompson, D., Dunning, A., Hayward, N.,
Armstrong, B., Cust, A., Holland, E., Kefford,
R., Mann, G., Schmid, H., et al (2014). Most
common 'sporadic' cancers have a significant
germline genetic component. Human Molecular
Genetics, 23(22), 6112-6118. <a
href="http://dx.doi.org/10.1093/hmg/ddu312">[
More Information]</a>
Becker, T., Boyd, S., Mijatov, B., Gowrishankar,
K., Snoyman, S., Pupo, G., Scolyer, R., Mann,
G., Kefford, R., Zhang, X., Rizos, H. (2014).
Mutant B-RAF-Mcl-1 survival signaling depends
on the STAT3 transcription factor. Oncogene,
33(9), 1158-1166. <a
href="http://dx.doi.org/10.1038/onc.2013.45">[
More Information]</a>
Barter, R., Schramm, S., Mann, G., Yang, J.
(2014). Network-based biomarkers enhance
classical approaches to prognostic gene
expression signatures. International Conference
on Bioinformatics 2014 (InCoB2014), Australia:
BMC Public Health. <a
href="http://dx.doi.org/10.1186/1752-0509-8-S4S5">[More Information]</a>
Watts, K., Meiser, B., Wakefield, C., Barratt, A.,
Howard, K., Cheah, B., Mann, G., Lobb, E.,
Gaff, C., Patel, M. (2014). Online Prostate
Cancer Screening Decision Aid for At-Risk Men:
A Randomized Trial. Health Psychology, 33(9),
986-997. <a
href="http://dx.doi.org/10.1037/a0034405">[Mo
re Information]</a>
Harland, M., Cust, A., Badenas, C., Chang, Y.,
Holland, E., Aguilera, P., Aitken, J., Armstrong,
B., Barrett, J., Carrera, C., Agha-Hamilton, C.,
Kefford, R., Kolm, I., Schmid, H., Mann, G., et
al (2014). Prevalence and predictors of germline
CDKN2A mutations for melanoma cases from
Australia, Spain and the United Kingdom.
Hereditary Cancer in Clinical Practice.
Mactier, S., Kaufman (nee Alexander), K.,
Wang, P., Crossett, B., Pupo, G., Kohnke, P.,
Thompson, J., Scolyer, R., Yang, J., Mann, G.,
Christopherson, R. (2014). Protein signatures
correspond to survival outcomes of AJCC stage
III melanoma patients. Pigment Cell &
Melanoma Research, 27(6), 1106-1116. <a
href="http://dx.doi.org/10.1111/pcmr.12290">[
More Information]</a>
Kaufman (nee Alexander), K., Mactier, S.,
Armstrong, N., Mallawaaratchy, D., Byrne, S.,
Haydu, L., Jakrot, V., Thompson, J., Mann, G.,
Scolyer, R., Christopherson, R. (2014). Surface
antigen profiles of leukocytes and melanoma
cells in lymph node metastases are associated
with survival in AJCC stage III melanoma
patients. Clinical and Experimental Metastasis,
31, 407-421. <a
href="http://dx.doi.org/10.1007/s10585-014-963
6-7">[More Information]</a>
Iles, M., Bishop, D., Taylor, J., Hayward, N.,
Brossard, M., Cust, A., Dunning, A., Lee, J.,
Moses, E., Akslen, L., Mann, G., et al (2014).
The Effect on Melanoma Risk of Genes
Previously Associated With Telomere Length.
Journal of the National Cancer Institute,
106(10). <a
href="http://dx.doi.org/10.1093/jnci/dju267">[M
ore Information]</a>
Sutton, S., Koach, J., Tan, O., Liu, B., Carter, D.,
Wilmott, J., Yosufi, B., Haydu, L., Mann, G.,
Thompson, J., Long, G., Scolyer, R., et al (2014).
TRIM16 inhibits proliferation and migration
through regulation of interferon beta 1 in
melanoma cells. Oncotarget, 5(20),
10127-10139.
2013
Iles, M., Law, M., Stacey, S., Han, J., Fang, S.,
Pfeiffer, R., Harland, M., MacGregor, S., Taylor,
J., Aben, K., Cust, A., Mann, G., et al (2013). A
variant in FTO shows association with melanoma
risk not due to BMI. Nature Genetics, 45(4),
428-432. <a
href="http://dx.doi.org/10.1038/ng.2571">[More
Information]</a>
Liu, H., Wang, L., Liu, Z., Chen, W., Amos, C.,
Lee, J., Iles, M., Law, M., Barrett, J.,
Montgomery, G., Cust, A., Mann, G., et al
(2013). Association between functional
polymorphisms in genes involved in the MAPK
signaling pathways and cutaneous melanoma
risk. Carcinogenesis, 34(4), 885-892. <a
href="http://dx.doi.org/10.1093/carcin/bgs407">[
More Information]</a>
Qian, J., Liu, H., Wei, S., Liu, Z., Li, Y., Wang,
Publications for Graham Mann
L., Chen, W., Amos, C., Lee, J., Iles, M., Cust,
A., Mann, G., et al (2013). Association between
putative functional variants in the PSMB9 gene
and risk of melanoma - re-analysis of published
melanoma genome-wide association studies.
Pigment Cell & Melanoma Research, 26(3),
392-401. <a
href="http://dx.doi.org/10.1111/pcmr.12069">[
More Information]</a>
href="http://dx.doi.org/10.416/onci.25564">[Mo
re Information]</a>
Mann, G., Pupo, G., Campain, A., Carter, C.,
Schramm, S., Pianova, S., Gerega, S., Desilva,
C., Lai, K., Wilmott, J., Hersey, P., Kefford, R.,
Thompson, J., Yang, J., Scolyer, R., et al (2013).
BRAF Mutation, NRAS Mutation, and the
Absence of an Immune-Related Expressed Gene
Profile Predict Poor Outcome in Patients with
Stage III Melanoma. Journal of Investigative
Dermatology, 133(2), 509-517. <a
href="http://dx.doi.org/10.1038/jid.2012.283">[
More Information]</a>
Cust, A., Goumas, C., Vuong, K., Davies, J.,
Barrett, J., Holland, E., Schmid, H.,
Agha-Hamilton, C., Armstrong, B., Kefford, R.,
Mann, G., et al (2013). MC1R genotype as a
predictor of early-onset melanoma, compared
with self-reported and physician-measured
traditional risk factors: An Australian
case-control-family study. BMC Cancer, 13(1),
1-13. <a
href="http://dx.doi.org/10.1186/1471-2407-13-4
06">[More Information]</a>
Mar, V., Wong, S., Li, J., Scolyer, R., McLean,
C., Papenfuss, A., Tothill, R., Kakavand, H.,
Mann, G., Thompson, J., et al (2013).
BRAF/NRAS Wild-Type Melanomas Have a
High Mutation Load Correlating with Histologic
and Molecular Signatures of UV Damage.
Clinical Cancer Research, 19(17), 4589-4598.
<a
href="http://dx.doi.org/10.1158/1078-0432.CCR13-0398">[More Information]</a>
McLoone, J., Watts, K., Menzies, S.,
Barlow-Stewart, K., Mann, G., Kasparian, N.
(2013). Melanoma survivors at high risk of
developing new primary disease: a qualitative
examination of the factors that contribute to
patient satisfaction with clinical care.
Psycho-Oncology, 22(9), 1994-2000. <a
href="http://dx.doi.org/10.1002/pon.3243">[Mor
e Information]</a>
Connolly, K., Dhillon, H., Mann, B., Chua, B.,
Segelov, E. (2013). Breast cancer: Screening,
prevention, support and other aspects. Medicine
Today, 14(8), 29-36.
Schramm, S., Li, S., Jayaswal, V., Fung, D.,
Campain, A., Pang, C., Scolyer, R., Yang, J.,
Mann, G., Wilkins, M. (2013). Disturbed
protein-protein interaction networks in metastatic
melanoma are associated with worse prognosis
and increased functional mutation burden.
Pigment Cell & Melanoma Research, 26(5),
708-722. <a
href="http://dx.doi.org/10.1111/pcmr.12126">[
More Information]</a>
Garcia-Closas, M., Couch, F., Lindstrom, S.,
Michailidou, K., Schmidt, M., Brook, M., Orr,
N., Rhie, S., Riboli, E., Feigelson, H., Carpenter,
J., Balleine, R., et al (2013). Genome-wide
association studies identify four ER
negative-specific breast cancer risk loci. Nature
Genetics, 45(4), 392-398. <a
href="http://dx.doi.org/10.1038/ng.2561">[More
Information]</a>
Kakavand, H., Scolyer, R., Thompson, J., Mann,
G. (2013). Identification of new prognostic
biomarkers for Stage III metastatic melanoma
patients. OncoImmunology, 2(9),
e25564-1-e25564-3. <a
Gyorki, D., Shaw, T., Nicholson, J., Baker, C.,
Pitcher, M., Skandarajah, A., Segelov, E., Mann,
B. (2013). Improving the impact of didactic
resident training with online spaced education.
ANZ Journal of Surgery, 83(6), 477-480. <a
href="http://dx.doi.org/10.1111/ans.12166">[Mo
re Information]</a>
Dutton-Regester, K., Kakavand, H., Aoude, L.,
Stark, M., Gartside, M., Johansson, P.,
O'Connor, L., Lanagan, C., Tembe, V., Pupo, G.,
Haydu, L., Mann, G., Thompson, J., Scolyer, R.,
et al (2013). Melanomas of unknown primary
have a mutation profile consistent with cutaneous
sun-exposed melanoma. Pigment Cell &
Melanoma Research, 26(6), 852-860. <a
href="http://dx.doi.org/10.1111/pcmr.12153">[
More Information]</a>
Schramm, S., Menzies, A., Mann, G. (2013).
Molecular biomarkers of prognosis in melanoma:
how far are we from the clinic? Melanoma
Research, 23(6), 423-425. <a
href="http://dx.doi.org/10.1097/CMR.00000000
00000001">[More Information]</a>
Schramm, S., Jayaswal, V., Goel, A., Li, S.,
Yang, J., Mann, G., Wilkins, M. (2013).
Molecular interaction networks for the analysis
of human disease: utility, limitations, and
considerations. Proteomics, 13(23-24),
3393-3405. <a
href="http://dx.doi.org/10.1002/pmic.201200570
">[More Information]</a>
Boyd, S., Mijatov, B., Pupo, G., Tran, S.,
Gowrishankar, K., Shaw, H., Goding, C.,
Scolyer, R., Mann, G., Kefford, R., Rizos, H.,
Becker, T. (2013). Oncogenic B-RAF(V600E)
Signaling Induces the T-Box3 Transcriptional
Publications for Graham Mann
Repressor to Repress E-Cadherin and Enhance
Melanoma Cell Invasion. Journal of
Investigative Dermatology, 133(5), 1269-1277.
<a
href="http://dx.doi.org/10.1038/jid.2012.421">[
More Information]</a>
McLoone, J., Menzies, S., Meiser, B., Mann, G.,
Kasparian, N. (2013). Psycho-educational
interventions for melanoma survivors: a
systematic review. Psycho-Oncology, 22(7),
1444-1456. <a
href="http://dx.doi.org/10.1002/pon.3165">[Mor
e Information]</a>
Jayaswal, V., Schramm, S., Mann, G., Wilkins,
M., Yang, J. (2013). VAN: an R package for
identifying biologically perturbed networks via
differential variability analysis. BMC Research
Notes, 6(1), 1-9. <a
href="http://dx.doi.org/10.1186/1756-0500-6-43
0">[More Information]</a>
2012
Dutton-Regester, K., Irwin, D., Hunt, P., Aoude,
L., Tembe, V., Pupo, G., Lanagan, C., Carter, C.,
O'Connor, L., O'Rourke, M., Scolyer, R., Mann,
G., et al (2012). A High-Throughput Panel for
Identifying Clinically Relevant Mutation Profiles
in Melanoma. Molecular Cancer Therapeutics,
11(4), 888-897. <a
href="http://dx.doi.org/10.1158/1535-7163.MCT
-11-0676">[More Information]</a>
Kim, J., McCarthy, S., Thompson, J., Pupo, G.,
Vonthethoff, L., Nash, P., Mann, G., Scolyer, R.
(2012). Cellular blue naevus involving the
urinary bladder. Pathology, 44(7), 664-668. <a
href="http://dx.doi.org/10.1097/PAT.0b013e328
359e142">[More Information]</a>
Dutton-Regester, K., Aoude, L., Nancarrow, D.,
Stark, M., O'Connor, L., Lanagan, C., Pupo, G.,
Tembe, V., Carter, C., O'Rourke, M., Scolyer,
R., Mann, G., et al (2012). Identification of TFG
(TRK-Fused Gene) as a Putative Metastatic
Melanoma Tumor Suppressor Gene. Genes
Chromosomes and Cancer, 51(5), 452-461. <a
href="http://dx.doi.org/10.1002/gcc.21932">[Mo
re Information]</a>
Cust, A., Goumas, C., Holland, E.,
Agha-Hamilton, C., Aitken, J., Armstrong, B.,
Giles, G., Kefford, R., Schmid, H., Hopper, J.,
Mann, G., et al (2012). MC1R genotypes and
risk of melanoma before age 40 years: A
population-based case-control-family study.
International Journal of Cancer, 131(3),
E269-2E81. <a
href="http://dx.doi.org/10.1002/ijc.27357">[Mor
e Information]</a>
Coates, E., Moloney, F., Guitera, P., Haass, N.,
Ho, K., Khoury, R., Mann, G., Menzies, S.
(2012). Melanoma detection in high risk patients:
a case series. 20th Regional Conference of
Dermatology 2012.
Law, M., Montgomery, G., Brown, K., Martin,
N., Mann, G., Hayward, N., MacGregor, S.
(2012). Meta-Analysis Combining New and
Existing Data Sets Confirms that the
TERT-CLPTM1L Locus Influences Melanoma
Risk. Journal of Investigative Dermatology,
132(2), 485-487. <a
href="http://dx.doi.org/10.1038/jid.2011.322">[
More Information]</a>
Moloney, F., Guitera, P., Coates, E., Haass, N.,
Ho, K., Khoury, R., Mann, G., Menzies, S.
(2012). Observation of a five year high risk
clinic for primary melanoma. 3rd World
Congress of Dermoscopy, Australia.
Schramm, S., Campain, A., Scolyer, R., Yang, J.,
Mann, G. (2012). Review and Cross-Validation
of Gene Expression Signatures and Melanoma
Prognosis. Journal of Investigative Dermatology,
132(2), 274-283. <a
href="http://dx.doi.org/10.1038/jid.2011.305">[
More Information]</a>
Scurr, L., McKenzie, H., Becker, T., Irvine, M.,
Lai, K., Mann, G., Scolyer, R., Kefford, R.,
Rizos, H. (2012). Selective Loss of Wild-Type
p16(INK4a) Expression in Human Nevi. Journal
of Investigative Dermatology, 131(11),
2329-2332. <a
href="http://dx.doi.org/10.1038/jid.2011.197">[
More Information]</a>
Howard, K., Salkeld, G., Mann, G., Patel, M.,
Cunich, M., Pignone, M. (2012). The COMPASs
Study: Community Preferences for Prostate
cAncer Screening. Protocol for a quantitative
preference study. BMJ Open, 2(1), 1-6. <a
href="http://dx.doi.org/10.1136/bmjopen-2011-0
00587">[More Information]</a>
Kasparian, N., Sansom-Daly, U., McDonald, R.,
Meiser, B., Butow, P., Mann, G. (2012). The
nature and structure of psychological distress in
people at high risk for melanoma: A factor
analytic study. Psycho-Oncology, 21(8),
845-856. <a
href="http://dx.doi.org/10.1002/pon.1976">[Mor
e Information]</a>
2011
Yokoyama, S., Woods, S., Boyle, G., Aoude, L.,
MacGregor, S., Zismann, V., Gartside, M., Cust,
A., Haq, R., Harland, M., Holland, E., Schmid,
H., Kefford, R., Armstrong, B., Mann, G., et al
(2011). A novel recurrent mutation in MITF
predisposes to familial and sporadic melanoma.
Nature, 480(7375), 99-103. <a
href="http://dx.doi.org/10.1038/nature10630">[
More Information]</a>
Publications for Graham Mann
Wakefield, C., Watts, K., Meiser, B.,
Sansom-Daly, U., Barratt, A., Mann, G., Lobb,
E., Gaff, C., Howard, K., Patel, M. (2011).
Development and pilot testing of an online
screening decision aid for men with a family
history of prostate cancer. Patient Education and
Counseling, 83(1), 64-72. <a
href="http://dx.doi.org/10.1016/j.pec.2010.05.02
5">[More Information]</a>
Cust, A., Jenkins, M., Goumas, C., Armstrong,
B., Schmid, H., Aitken, J., Giles, G., Kefford, R.,
Hopper, J., Mann, G. (2011). Early-life sun
exposure and risk of melanoma before age 40
years. Cancer Causes and Control, 22(6),
885-897. <a
href="http://dx.doi.org/10.1007/s10552-011-976
2-3">[More Information]</a>
MacGregor, S., Montgomery, G., Liu, J., Zhao,
Z., Henders, A., Stark, M., Schmid, H., Holland,
E., Duffy, D., Zhang, M., Cust, A., Kefford, R.,
Armstrong, B., Mann, G., et al (2011).
Genome-wide association study identifies a new
melanoma susceptibility locus at 1q21.3. Nature
Genetics, 43(11), 1114-1119. <a
href="http://dx.doi.org/10.1038/ng.958">[More
Information]</a>
Amos, C., Wang, L., Lee, J., Gershenwald, J.,
Chen, W., Fang, S., Kosoy, R., Zhang, M.,
Qureshi, A., Vattathil, S., Mann, G., Cust, A., et
al (2011). Genome-wide association study
identifies novel loci predisposing to cutaneous
melanoma. Human Molecular Genetics, 20(24),
5012-5023. <a
href="http://dx.doi.org/10.1093/hmg/ddr415">[
More Information]</a>
Barrett, J., Iles, M., Harland, M., Taylor, J.,
Aitken, J., Andresen, P., Akslen, L., Armstrong,
B., Avril, M., Azizi, E., Cust, A., Kefford, R.,
Mann, G., et al (2011). Genome-wide association
study identifies three new melanoma
susceptibility loci. Nature Genetics, 43(11),
1108-1113. <a
href="http://dx.doi.org/10.1038/ng.959">[More
Information]</a>
Hersey, P., Smalley, K., Weeraratna, A.,
Bosenberg, M., Zhang, X., Haass, N., Paton, E.,
Mann, G., Scolyer, R. (2011). Meeting report
from the 7th International Melanoma Congress,
Sydney, November, 2010. Pigment Cell &
Melanoma Research, 24(1), e1-e15. <a
href="http://dx.doi.org/10.1111/j.1755-148X.201
0.00811.x">[More Information]</a>
Schramm, S., Mann, G. (2011). Melanoma
Prognosis: A REMARK-based systematic review
and bioinformatic analysis of
immunohistochemical and gene microarray
studies. Molecular Cancer Therapeutics, 10(8),
1520-1528. <a
href="http://dx.doi.org/10.1158/1535-7163.MCT
-10-0901">[More Information]</a>
Cust, A., Harland, M., Makalic, E., Schmidt, D.,
Dowty, J., Aitken, J., Agha-Hamilton, C.,
Armstrong, B., Barrett, J., Chan, M., Holland, E.,
Kefford, R., Schmid, H., Mann, G., et al (2011).
Melanoma risk for CDKN2A mutation carriers
who are relatives of population-based case
carriers in Australia and the UK. Journal of
Medical Genetics, 48(4), 266-272. <a
href="http://dx.doi.org/10.1136/jmg.2010.08653
8">[More Information]</a>
Long, G., Menzies, A., Nagrial, A., Haydu, L.,
Hamilton, A., Mann, G., Hughes, T., Thompson,
J., Scolyer, R., Kefford, R. (2011). Prognostic
and Clinicopathologic Associations of
Oncogenic BRAF in Metastatic Melanoma.
Journal of Clinical Oncology, 29(10),
1239-1246. <a
href="http://dx.doi.org/10.1200/JCO.2010.32.43
27">[More Information]</a>
Cust, A., Armstrong, B., Goumas, C., Jenkins,
M., Schmid, H., Hopper, J., Kefford, R., Giles,
G., Aitken, J., Mann, G. (2011). Sunbed Use
During Adolescence and Early Adulthood is
Associated with Increased Risk of Early-Onset
Melanoma. International Journal of Cancer,
128(10), 2425-2435. <a
href="http://dx.doi.org/10.1002/ijc.25576">[Mor
e Information]</a>
2010
Kaufman (nee Alexander), K., Belov, L., Huang,
P., Mactier, S., Scolyer, R., Mann, G.,
Christopherson, R. (2010). An extended antibody
microarray for surface profiling metastatic
melanoma. Journal of Immunological Methods,
358(40210 (1-2)), 23-34. <a
href="http://dx.doi.org/10.1016/j.jim.2010.03.01
7">[More Information]</a>
Demenais, F., Mohamdi, H., Chaudru, V.,
Goldstein, A., Newton Bishop, J., Bishop, D.,
Kanetsky, P., Hayward, N., Gillanders, E., Elder,
D., Holland, E., Mann, G., et al (2010).
Association of MC1R Variants and Host
Phenotypes With Melanoma Risk in CDKN2A
Mutation Carriers: A GenoMEL Study. Journal
of the National Cancer Institute, 102(20),
1568-1583. <a
href="http://dx.doi.org/10.1093/jnci/djq363">[M
ore Information]</a>
Balleine, R., Provan, P., Pupo, G., Pathmanathan,
N., Cummings, M., Farshid, G., Salisbury, E.,
Bilous, M., Byth Wilson, K., kConFab
Investigators., Mann, G. (2010). Familial
Concordance of Breast Cancer Pathology as an
Indicator of Genotype in Multiple-Case Families.
Genes Chromosomes and Cancer, 49(12),
1082-1094. <a
Publications for Graham Mann
href="http://dx.doi.org/10.1002/gcc.20816">[Mo
re Information]</a>
Scurr, L., Pupo, G., Becker, T., Lai, K., Schrama,
D., Haferkamp, S., Irvine, M., Scolyer, R.,
Mann, G., Becker, J., Kefford, R., Rizos, H.
(2010). IGFBP7 Is Not Required for
B-RAF-Induced Melanocyte Senescence. Cell,
141(4), 717-727. <a
href="http://dx.doi.org/10.1016/j.cell.2010.04.02
1">[More Information]</a>
McKenzie, H., Fung, C., Becker, T., Irvine, M.,
Mann, G., Kefford, R., Rizos, H. (2010).
Predicting functional significance of
cancer-associated p16(INK4a) mutations in
CDKN2A. Human Mutation, 31(6), 692-701. <a
href="http://dx.doi.org/10.1002/humu.21245">[
More Information]</a>
Kasparian, N., Mcloone, J., Meiser, B., Butow,
P., Simpson, J., Mann, G. (2010). Skin cancer
screening behaviours among individuals with a
strong family history of malignant melanoma.
British Journal of Cancer, 103, 1502-1509. <a
href="http://dx.doi.org/10.1038/sj.bjc.6605942">
[More Information]</a>
2009
Howard, K., Barratt, A., Mann, G., Patel, M.
(2009). A model of prostate-specific antigen
screening outcomes for low- to high-risk men:
information to support informed choices.
Archives of Internal Medicine, 169(17),
1603-1610. <a
href="http://dx.doi.org/10.1001/archinternmed.2
009.282">[More Information]</a>
Morey, A., Murali, R., McCarthy, S., Mann, G.,
Scolyer, R. (2009). Diagnosis of cutaneous
melanocytic tumours by four-colour fluorescence
in situ hybridisation. Pathology, 41(4), 383-387.
<a
href="http://dx.doi.org/10.1080/0031302090291
5875">[More Information]</a>
Scaini, M., Rossi, E., Torres, P., Zullato, D.,
Callegaro, M., Casella, C., Quaggio, M., Agata,
S., Malacrida, S., Chiarion-Sileni, V., Mann, G.,
et al (2009). Functional impairment of
p16(INK4A) due to CDKN2A p.Gly23Asp
missense mutation. Mutation Research:
Fundamental and Molecular Mechanisms of
Mutagenesis, 671(1), 26-32. <a
href="http://dx.doi.org/10.1016/j.mrfmmm.2009.
08.007">[More Information]</a>
Kasparian, N., Meiser, B., Butow, P., Simpson,
J., Mann, G. (2009). Genetic testing for
melanoma risk: a prospective cohort study of
uptake and outcomes among Australian families.
Genetics in Medicine, 11(4), 265-278. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=19265718">[More Information]</a>
Bishop, D., Demenais, F., Iles, M., Harland, M.,
Taylor, J., Corda, E., Randerson-Moor, J.,
Aitken, J., Kefford, R., Mann, G. (2009).
Genome-wide association study identifies three
loci associated with melanoma risk. Nature
Genetics, 41(8), 920-925. <a
href="http://dx.doi.org/10.1038/ng.411">[More
Information]</a>
Gartside, M., Chen, H., Ibrahimi, O., Byron, S.,
Curtis, A., Wellens, C., Bengston, A., Yudt, L.,
Eliseenkova, A., Ma, J., Mann, G., et al (2009).
Loss-of-function fibroblast growth factor
receptor-2 mutations in melanoma. Molecular
Cancer Research, 7(1), 41-54. <a
href="http://dx.doi.org/10.1158/1541-7786.MCR
-08-0021">[More Information]</a>
Cust, A., Schmid, H., Maskiell, J., Jetann, J.,
Ferguson, M., Holland, E., Agha-Hamilton, C.,
Jenkins, M., Kelly, J., Kefford, R., Armstrong,
B., Mann, G., et al (2009). Population-based,
Case-Control-Family Design to Investigate
Genetic and Environmental Influences on
Melanoma Risk: Australian Melanoma Family
Study. American Journal of Epidemiology,
170(12), 1541-1554. <a
href="http://dx.doi.org/10.1093/aje/kwp307">[M
ore Information]</a>
Leachman, S., Carucci, J., Kohlmann, W.,
Banks, K., Asgari, M., Bergman, W.,
Bianchi-Scarra, G., Brentnall, T., Bressac-de
Paillerets, B., Bruno, W., Kefford, R., Mann, G.
(2009). Selection criteria for genetic assessment
of patients with familial melanoma. Journal Of
The American Academy Of Dermatology, 61(4),
677.e1-677.e14. <a
href="http://dx.doi.org/10.1016/j.jaad.2009.03.01
6">[More Information]</a>
Becker, T., Haferkamp, S., Dijkstra, M., Scurr,
L., Frausto, M., Diefenbach, E., Scolyer, R.,
Reisman, D., Mann, G., Kefford, R., Rizos, H.
(2009). The chromatin remodelling factor BRG1
is a novel binding partner of the tumor
suppressor p16INK4a. Molecular Cancer, 8(4),
4-1-4-12. <a
href="http://dx.doi.org/10.1186/1476-4598-8-4"
>[More Information]</a>
2008
Mann, G., Harland, M., Goldstein, A.,
Kukalizch, K., Taylor, C., Hogg, D., Puig, S.,
Badenase, C., Gruis, N., ter Huurnef, J., et al
(2008). A comparison of CDKN2A mutation
detection within the Melanoma Genetics
Consortium (GenoMEL). European Journal of
Cancer, 44(9), 1269-1274. <a
href="http://dx.doi.org/10.1016/j.ejca.2008.03.00
5">[More Information]</a>
Publications for Graham Mann
Thompson, J., Armstrong, B., Barbour, A.,
Barnetson, R., Beanland, H., Beer, T.,
Brookshank, M., Burmeister, B., Butow, P.,
Clark, K., Conway, R., Damian, D., Frommer,
M., Kefford, R., Lee, S., Mason, R., Mann, G.,
McCarthy, W., Menzies, S., Olver, I., Quinn, M.,
Saw, R., Shaw, H., Stretch, J., Barraclough, B.,
Holt, P., Reeve, T., et al (2008).
Brown, K., MacGregor, S., Montgomery, G.,
Craig, D., Zhao, Z., Iyadurai, K., Henders, A.,
Homer, N., Campbell, M., Stark, M., Schmid, H.,
Holland, E., Kefford, R., Armstrong, B., Mann,
G., et al (2008). Common sequence variants on
20q11.22 confer melanoma susceptibility. Nature
Genetics, 40(7), 838-840. <a
href="http://dx.doi.org/10.1038/ng.163">[More
Information]</a>
Kasparian, N., Butow, P., Meiser, B., Mann, G.
(2008). High- and average-risk individuals'
beliefs about, and perceptions of, malignant
melanoma: an Australian perspective.
Psycho-Oncology, 17(3), 270-279. <a
href="http://dx.doi.org/10.1002/pon.1230">[Mor
e Information]</a>
Wong, E., Tesoriero, A., Pupo, G., Mann, G.,
KConFab, C., ABCFS, T., McCredie, M., Giles,
G., Hopper, J., Hopper, G., et al (2008). Is MSH2
a breast cancer susceptibility gene? Familial
Cancer, 7(2), 151-155. <a
href="http://dx.doi.org/10.1007/s10689-007-916
2-8">[More Information]</a>
Wakefield, C., Meiser, B., Gaff, C., Barratt, A.,
Patel, M., Suthers, G., Lobb, E., Ramsay, J.,
Mann, G. (2008). Issues Faced by Unaffected
Men With a Family
History of Prostate Cancer: A Multidisciplinary
Overview. The Journal of Urology, 180(1),
38-46. <a
href="http://dx.doi.org/10.1016/j.juro.2008.03.02
0">[More Information]</a>
Gallagher, S., Thompson, J., Indsto, J., Scurr, L.,
Lett, M., Gao, B., Dunleavey, R., Mann, G.,
Kefford, R., Rizos, H. (2008). p16INK4a
expression and absence of activated B-RAF are
independent predictors of chemosensitivity in
melanoma tumors. NeoPlasia: an international
journal of oncology research, 10(11),
1231-1239. <a
href="http://dx.doi.org/10.1593/neo.08702">[Mo
re Information]</a>
Kasparian, N., Meiser, B., Butow, P., Simpson,
J., Mann, G. (2008). Predictors of psychological
distress among individuals with a strong family
history of malignant melanoma. Clinical
Genetics, 73(2), 121-131. <a
href="http://dx.doi.org/10.1111/j.1399-0004.200
7.00949.x">[More Information]</a>
2007
Kasparian, N., Meiser, B., Butow, P., Job, R.,
Mann, G. (2007). Anticipated uptake of genetic
testing for familial melanoma in an Australian
sample: An exploratory study. Psycho-Oncology,
16(1), 69-78.
Lose, F., Arnold, J., Young, D., Brown, C.,
Mann, G., Pupo, G., Khanna, K.,
Chenevix-Trench, G., Spurdle, A. (2007).
BCoR-L1 variation and breast cancer. Breast
Cancer Research, 9(4), 1-12. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=17697391">[More Information]</a>
Esquivel, J., Sticca, R., Sugarbaker, P., Levine,
E., Yan, T., Alexander, R., Baratti, D., Bartlett,
D., Barone, R., Barrios, P., et al (2007).
Cytoreductive surgery and hyperthermic
intraperitoneal chemotherapy in the management
of peritoneal surface malignancies of colonic
origin: a consensus statement. Society of
Surgical Oncology. Annals of Surgical
Oncology, 14(1), 128-133. <a
href="http://dx.doi.org/10.1245/s10434-006-918
5-7">[More Information]</a>
Gurney, H., Wong, M., Balleine, R., Rivory, L.,
McLachlan, A., Hoskins, J., Wilcken, N., Clarke,
C., Mann, G., Collins, M., et al (2007). Imatinib
Disposition and ABCB1 (MDR1,
P-Glycoprotein) Genotype. Clinical
Pharmacology & Therapeutics, 82(1), 33-40. <a
href="http://dx.doi.org/10.1038/sj.clpt.6100201"
>[More Information]</a>
Indsto, J., Kumar, S., Wang, L., Crotty, K.,
Arbuckle, S., Mann, G. (2007). Low prevalence
of RAS-RAF-activating mutations in Spitz
melanocytic nevi compared with other
melanocytic lesions. Journal Of Cutaneous
Pathology, 34(6), 448-455. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=17518771">[More Information]</a>
Marsh, A., Healey, S., Lewis, A., Spurdle, A.,
Kedda, M., Khanna, K., Mann, G., Pupo, G.,
Lakhani, S., Chenevix-Trench, G. (2007).
Mutation analysis of five candidate genes in
familial breast cancer. Breast Cancer Research
and Treatment, 105(3), 377-389. <a
href="http://dx.doi.org/10.1007/s10549-006-946
1-z">[More Information]</a>
2006
Mann, G., Pupo, G., Newman, B.,
Chenevix-Trench, G., McGuffog, L., Southey,
M., Easton, D., Szabo, C., Renard, H., Odefrey,
F., et al (2006). A genome wide linkage search
for breast cancer susceptibility genes. Genes
Chromosomes and Cancer, 45(7). <a
Publications for Graham Mann
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16575876">[More Information]</a>
Mann, G., Thorne, H., Balleine, R., Butow, P.,
Clarke, C., Edkins, E., Evans, G., Fereday, S.,
Haan, E., Gattas, M., Kirk, J., Leary, J., Pupo,
G., et al (2006). Analysis of cancer risk and
BRCA1 and BRCA2 mutation prevalence in the
kConFab familial breast cancer resource. Breast
Cancer Research, 8(1), 1-15. <a
href="http://dx.doi.org/10.1186/bcr1377">[More
Information]</a>
Kasparian, N., Meiser, B., Butow, P., Soames
Job, R., Mann, G. (2006). Anticipated uptake of
genetic testing for familial melanoma in an
Australian sample: an exploratory study.
Psycho-Oncology, 16(1), 69-78. <a
href="http://dx.doi.org/10.1002/pon.1052">[Mor
e Information]</a>
Kasparian, N., Meiser, B., Butow, P., Job, R.,
Mann, G. (2006). Better the devil you know.
High risk individuals' anticipated psychological
responses to genetic testing for melanoma
susceptibility. Journal of Genetic Counseling,
15(6), 433-447. <a
href="http://dx.doi.org/10.1007/s10897-006-903
8-3">[More Information]</a>
Goldstein, A., Chan, M., Harland, M., Hayward,
N., Demenais, F., Bishop, D., Azizi, E.,
Bergman, W., Bianchi-Scarra, G., Bruno, W.,
Holland, E., Kefford, R., Mann, G., et al (2006).
Features associated with germline CDKN2A
mutations: A GenoMEL study of
melanoma-prone families from three continents.
Journal of Medical Genetics, 44(2), 99-106. <a
href="http://dx.doi.org/10.1136/jmg.2006.04380
2">[More Information]</a>
Goldstein, A., Chan, M., Harland, M.,
Gillanders, E., Hayward, N., Avril, M., Azizi, E.,
Bianchi-Scarra, G., Bishop, D., Bressac-de
Paillerets, B., Holland, E., Kefford, R., Mann,
G., et al (2006). High-risk melanoma
susceptibility genes and pancreatic cancer, neural
system tumors, and uveal melanoma across
GenoMEL. Cancer Research, 66(20),
9818-9828. <a
href="http://dx.doi.org/10.1158/0008-5472.CAN
-06-0494">[More Information]</a>
WONG, M., Balleine, R., Blair, E., McLachlan,
A., Ackland, S., Garg, M., Evans, S., Farlow, D.,
Collins, M., Rivory, L., Hoskins, J., Mann, G.,
Clarke, C., Gurney, H. (2006). Predictors of
Vinorelbine Pharmacokinetics and
Pharmacodynamics in Patients With Cancer.
Journal of Clinical Oncology, 24(16),
2448-2455. <a
href="http://dx.doi.org/10.1200/JCO.2005.02.12
95">[More Information]</a>
Lose, F., Lovelock, P., Chenevix-Trench, G.,
Mann, G., Pupo, G., Spurdle, A. (2006).
Variation in the RAD51 gene and familial breast
cancer. Breast Cancer Research, 8(3), R26-R26.
<a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16762046">[More Information]</a>
2005
Wong, M., Evans, S., Rivory, L., Hoskins, J.,
Mann, G., Farlow, D., Clarke, C., Balleine, R.,
Gurney, H. (2005). Hepatic technetium Tc
99m-labeled sestamibi elimination rate and
ABCB1 (MDR1) genotype as indicators of
ABCB1 (P-glycoprotein) activity in patients with
cancer. Clinical Pharmacology & Therapeutics,
77(1), 33-42. <a
href="http://dx.doi.org/10.1016/j.clpt.2004.09.00
2">[More Information]</a>
Becker, T., Rizos, H., Dela Pena, A., Leclercq, I.,
Woodruff, S., Kefford, R., Mann, G. (2005).
Impaired inhibition of NF-kappaB activity by
melanoma-associated p16INK4a mutations.
Biochemical and Biophysical Research
Communications, 332(3), 873-879. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=15913553">[More Information]</a>
Harland, M., Taylor, C., Bass, S., Churchman,
M., Randerson-Moor, J., Holland, E., Mann, G.,
Bishop, D., Newton Bishop, J. (2005). Intronic
sequence variants of the CDKN2A gene in
melanoma pedigrees. Genes Chromosomes and
Cancer, 43(2), 128-136. <a
href="http://dx.doi.org/10.1002/gcc.20177">[Mo
re Information]</a>
Lewis, A., Flanagan, J., Marsh, A., Pupo, G.,
Mann, G., Spurdle, A., Lindeman, G., Visvader,
J., Brown, M., Chenevix-Trench, G., et al (2005).
Mutation analysis of FANCD2, BRIP1/BACH1,
LMO4 and SFN in familial breast cancer. Breast
Cancer Research, 7(6), R1005-R1016. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16280053">[More Information]</a>
Becker, T., Ayub, A., Kefford, R., Mann, G.,
Rizos, H. (2005). The melanoma-associated 24
base pair duplication in p16INK4a is functionally
impaired. International Journal of Cancer,
117(4), 569-573. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=15945100">[More Information]</a>
2004
Walker, G., Indsto, J., Sood, R., Faruque, M.,
Hu, P., Pollock, P., Duray, P., Holland, E.,
Brown, K., Kefford, R., Mann, G., et al (2004).
Publications for Graham Mann
Deletion Mapping Suggests That The 1P22
Melanoma Susceptibility Gene Is A Tumor
Suppressor Localized To A 9-Mb Interval. Genes
Chromosomes and Cancer, 41(1), 56-64. <a
href="http://dx.doi.org/10.1002/gcc.20056">[Mo
re Information]</a>
2003
Clancy, J., Henderson, M., Russell, A.,
Anderson, D., Bova, R., Campbell, I., Choong,
D., Macdonald, G., Mann, G., Nolan, T., Davies,
M., et al (2003). EDD, the human orthologue of
the hyperplastic discs tumour suppressor gene, is
amplified and overexpressed in cancer.
Oncogene, 22(32), 5070-5081. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=12902990">[More Information]</a>
Camp, E., Badhwar, P., Mann, G., Lardelli, M.
(2003). Expression analysis of a tyrosinase
promoter sequence in zebrafish. Pigment Cell
Research, 16(2), 117-126.
Indsto, J., Nassif, N., Kefford, R., Mann, G.
(2003). Frequent loss of heterozygosity targeting
the inactive X chromosome in melanoma.
Clinical Cancer Research, 9(17), 6476-6482.
Kefford, R., Mann, G. (2003). Is there a role for
genetic testing in patients with melanoma?
Current Opinion in Oncology, 15(2), 157-161.
Gillanders, E., Juo, S., Holland, E., Jones, M.,
Nancarrow, D., Freas-Lutz, D., Sood, R., Park,
N., Faruque, M., Markey, C., Kefford, R., Mann,
G., et al (2003). Localization of a novel
melanoma susceptibility locus to 1p22. American
Journal of Human Genetics, 73(2), 301-313. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=12844286">[More Information]</a>
Hornbuckle, J., Culjak, G., Jarvis, E., Gebski, V.,
Coates, A., Mann, G., Kefford, R. (2003).
Patterns of metastases in familial and
non-familial melanoma. Melanoma Research,
13(1), 105-109.
2002
Chenevix-Trench, G., Spurdle, A., Gatei, M.,
Kelly, H., Marsh, A., Chen, X., Donn, K.,
Cummings, M., Nyholt, D., Jenkins, M., Pupo,
G., Kirk, J., Tucker, P., Mann, G., et al (2002).
Dominant Negative ATM Mutations in Breast
Cancer Families. Journal of the National Cancer
Institute, 94(3), 205-215.
Fung, D., Holland, E., Becker, T., Hayward, N.,
Bressac de Paillerets, B., Melanoma Genetics
Consortium, M., Mann, G. (2002).
EMelanoBase: An Online Locus-Specific
Variant Database for Familial Melanoma.
Human Mutation, 21(1), 2-7.
Thompson, D., Szabo, C., Mangion, J.,
Oldenburg, R., Odefrey, F., Seal, S., Barfoot, R.,
Kroeze-Jansema, K., Teare, D., Rahman, N.,
Mann, G., et al (2002). Evaluation of linkage of
breast cancer to the putative BRCA3 locus on
chromosome 13q21 in 128 multiple case families
from the Breast Cancer Linkage Consortium.
Proceedings of the National Academy of
Sciences of the United States of America (PNAS),
99(2), 827-831.
Bishop, D., Demenais, F., Goldstein, A.,
Bergman, W., Bishop, J., Bressac de Paillerets,
B., Chompret, A., Ghiorzo, P., Gruis, N.,
Hansson, J., Holland, E., Mann, G., et al (2002).
Geographical Variation in the Penetrance of
CDKN2A Mutations for Melanoma. Journal of
the National Cancer Institute, 94(12), 894-903.
2001
Indsto, J., Cachia, A., Kefford, R., Mann, G.
(2001). Clonality analysis, deletions and
microsatellite instability in common acquired
melanocytic nevi compared with malignant
melanoma. Clinical Cancer Research, 7(12),
4054-4059.
Becker, T., Rizos, H., Kefford, R., Mann, G.
(2001). Functional Impairment of
Melanoma-associated p16 INK4a mutants in
melanoma cells despite retention of
cyclin-dependent kinase 4 binding1. Clinical
Cancer Research, 7, 3282-3288.
Rizos, H., Darmanian, A., Mann, G., Kefford, R.,
Holland, E. (2001). Mutations in the INK4a/ARF
Melanoma Susceptibility locus functionally
impair p14ARF. Journal of Biological
Chemistry, 276(44), 41424-41434.
Shannon, J., Kefford, R., Mann, G. (2001).
Responses to ultraviolet-B in cell lines from
hereditary melanoma kindreds. Melanoma
Research, 11(1), 1-9.
Marsh, A., Spurdle, A., Turner, B., Fereday, S.,
Thorne, H., Pupo, G., Mann, G., Hopper, J.,
Sambrook, J., Chenevix-Trench, G., et al (2001).
The intronic G13964C variant in p53 is not a
high-risk mutation in familial breast cancer in
Australia. Breast Cancer Research, 3(5),
346-349.
Indsto, J., Cachia, A., Kefford, R., Mann, G.
(2001). X inactivation, DNA deletion, and
microsatellite instability in common acquired
melanocytic nevi. Clinical Cancer Research,
7(12), 4054-4059.
2000
Cachia, A., Indsto, J., McLaren, K., Mann, G.,
Arends, M. (2000). CDKN2A mutation and
deletion status in thin and thick primary
melanoma. Clinical Cancer Research, 6(9),
Publications for Graham Mann
3511-3515.
Harland, M., Holland, E., Ghiorzo, P., Mantelli,
M., Bianchi-Scarra, G., Goldstein, A., Tucker,
M., Ponder, B., Mann, G., Bishop, D., et al
(2000). Mutation screening of the CDKN2A
promoter in melanoma families. Genes
Chromosomes and Cancer, 28(1), 45-57.
Rizos, H., Darmanian, A., Mann, G., Kefford, R.
(2000). Two arginine rich domains in the
p14ARF tumour suppressor mediate nucleolar
localization. Oncogene, 19(26), 2978-2985.